secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biofrontera Inc. (BFRI)
CIK:        0001858685
Form:       8-K
Filed at:   2026-01-07T23:59:59+00:00
Accession:  0001493152-26-000823
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Biofrontera receives Nasdaq deficiency notice for bid price below $1.00 for 34 days
--------------------------------------------------------------------------------

- Nasdaq notice on Dec 31, 2025: common stock not compliant with Listing Rule 5550(a)(2) due to closing bid below $1.00.
- Company has 180 calendar days, until June 30, 2026, to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not cured, company may qualify for second 180-day period by meeting other continued listing standards and indicating intent to cure via reverse stock split.
- Failure to cure could lead to delisting; company plans to monitor and consider available options.
- No immediate impact on trading; Biofrontera common trades on Nasdaq under symbol BFRI.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858685/000149315226000823/0001493152-26-000823-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858685/000149315226000823/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-000823

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer